SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    MacIntyre I, Zaidi M, Towhidul ASM, Datta HK, Moonga BS, Lidbury PS, Hecker M, Vane JM 1991 Osteoclast inhibition: An action of nitric oxide not mediated by cyclic GMP. Proc Natl Acad Sci USA 88:29362940.
  • 2
    Kasten TP, Collin-Osdoby P, Patel N, Osdoby P, Krukowski M, Misko T, Settle SL, Currie MG, Nickols GA 1994 Potentiation of osteoclastic bone resorbing activity by inhibition of nitric oxide synthase. Proc Natl Acad Sci USA 91:35693573.
  • 3
    Lowik CWGM, Nibbering PH, Van der Ruit M, Papapoulos SE 1994 Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption. J Clin Invest 93:14651472.
  • 4
    Collin-Osdoby P, Nickols GA, Osdoby P 1995 Bone cell function, regulation, and communication: A role for nitric oxide. J Cell Biochem 57:399408.
  • 5
    Wimalawansa SJ 1989 Calcitonin gene-related peptide: Isolation, distribution and receptor binding. Ph.D. thesis, University of London, London, U.K.
  • 6
    Chae HJ, Park RK, Chung HT, Kang JS, Kim MS, Choi DY, Bang BG, Kim HR 1997 Nitric oxide is a regulator of bone remodeling. J Pharm Pharmacol 49:897902.
  • 7
    Wimalawansa SJ, De Marco G, Gangula P, Yallampalli C 1996 Nitric oxide donor alleviates ovariectomy-induced bone loss. Bone 18:301304.
  • 8
    Wimalawansa SJ, Chapa M, Yallampalli C, Zhang R, Simmons D 1997 Prevention of corticosteroid-induced bone loss with nitric oxide donor nitroglycerin in male rats. Bone 21:275280.
  • 9
    Brandi ML, Hukkanen M, Umeda T, Maradi-Bidhendi N, Bianchi S, Gross SS, Polak JM, MacIntyre I 1995 Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms. Proc Natl Acad Sci USA 92:29542958.
  • 10
    Kawase T, Howard GA, Roos BA, Burns DM 1993 Nitric oxide stimulates mineralization in osteoblastic cell cultures. J Bone Miner Res 8:S372.
  • 11
    Wimalawansa SM, Chapa T, Fang L, Yallampalli C, Simmons D, Wimalawansa SJ 2000 Frequency-dependent effect of nitric oxide donor, nitroglycerin on bone. J Bone Miner Res 15:11191125.
  • 12
    Ralston SH, Todd D, Helfrich M, Benjamin N, Grabowski S 1994 Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase. Endocrinology 135:330336.
  • 13
    Hukkanen M, Hughes FJ, Buttery LD, Gross SS, Seddon S, Riveros-Moreno V, MacIntyre I, Polak JM 1995 Cytokine-stimulated expression of inducible nitric oxide synthase by mouse, rat, and human osteoblast-like cells and its functional role in osteoblast metabolic activity. Endocrinology 136:54455453.
  • 14
    Ralston SH, Ho LP, Helfrich MH, Grabowski PS, Johnston PW, Benjamin N 1995 Nitric oxide: A cytokine-induced regulator of bone resorption. J Bone Miner Res 10:10401049.
  • 15
    Fox SW, Chambers TJ, Chow JWM 1996 Nitric oxide is an early mediator of the increase in bone formation by mechanical stimulation. Am J Physiol 270:E955E960.
  • 16
    Turner CH, Takano, Owan I, Murrell GAC 1996 Nitric oxide inhibitor L-NAME suppresses mechanically induced bone formation in rats. Am J Physiol 270:E634E639.
  • 17
    Wimalawansa SJ 2000 Restortation of ovariectomy-induced osteopenia by nitroglycerin. Calcif Tissue Int 66:5660.
  • 18
    Conference report 1993 Consensus Development Conference: Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 94:646650.
  • 19
    Nilas L, Christiansen C 1988 Rates of bone loss in normal women: Evidence of accelerated trabecular bone loss after the menopause. Eur J Clin Invest 18:529534.
  • 20
    Needleman P, Johnson EM Jr 1973 Mechanism of tolerance development to organic nitrates. J Pharmacol Exp Ther 184:709715.
  • 21
    Parker JD, Parker JO 1998 Nitrate therapy for stable angina pectoris. N Engl J Med 338:520531.
  • 22
    Strom T, Eslin R, Porter ES, Musgrave K, Vereault D, Patton C, Kessenich C, Mohan S, Chen T, Holick MF, Rosen CJ 1998 Calcium supplementation prevents seasonal bone loss and changes in biochemical markers of bone turnover in elderly New England women: A randomized placebo-controlled trial. J Clin Endocrinol Metab 83:38173825.
  • 23
    Rosen CJ, Tenenhouse A 1998 Biochemical markers of bone turnover—a look at laboratory tests that reflect bone status. Postgrad Med 104:101112.
  • 24
    Riggs BL, Melton LJ 1992 The prevention and treatment of osteoporosis. N Engl J Med 327:620627.
  • 25
    Baran DT 1994 Osteoporosis: Monitoring techniques and alternative therapies. Calcitonin, fluoride, biphosphonates, vitamin D. Obstet Gynecol Clin North Am 21:32135.
  • 26
    RonaldA (ed.) 1999 Physicians desk reference (PDR). Nitric oxide and nitroglycerin. United States Department of Health.
  • 27
    Lindsay R, Cossman F 1990 Estrogen in prevention and treatment of osteoporosis. Ann NY Acad Sci 592:326345.
  • 28
    Stacy E, Korkia P, Hukkanen MVJ, Polak JM, Rutherford OM 1998 Decreased nitric oxide levels and bone turnover in amenorrheic athletes with spinal osteopenia. J Clin Endocrinol Metab 83:30563061.
  • 29
    Rosselli M, Imthurn B, Keller PJ, Jackson EK, Dubey RK 1995 Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17β-estradiol and norethisterone acetate. Hypertension 25:848853.
  • 30
    Rosselli M, Imthurn B, Keller PJ, Jackson EK, Dubey RK 1994 Circulating nitrite/nitrate levels increases with follicular development: Indirect evidence for estradiol-mediated NO release. Biochem Biophys Res Commun 202:15431552.